Ridgewood Investments’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.09M Buy
+38,948
New +$1.04M 0.45% 71
2025
Q3
$1.46M Buy
76,186
+13,649
+22% +$337K 0.62% 46
2025
Q2
$1.52M Sell
62,537
-18,288
-23% -$426K 0.65% 41
2025
Q1
$1.58M Buy
80,825
+22,377
+38% +$586K 0.74% 30
2024
Q4
$1.55M Buy
58,448
+6,925
+13% +$188K 0.75% 28
2024
Q3
$1.49M Sell
51,523
-5,275
-9% -$154K 0.74% 28
2024
Q2
$1.59M Sell
56,798
-402
-0.7% -$11.1K 0.8% 24
2024
Q1
$1.59M Buy
57,200
+16,580
+41% +$460K 0.84% 29
2023
Q4
$1.17M Buy
40,620
+4,532
+13% +$137K 0.69% 40
2023
Q3
$1.2M Buy
36,088
+8,012
+29% +$283K 0.79% 35
2023
Q2
$1.03M Buy
28,076
+22,277
+384% +$867K 0.59% 46
2023
Q1
$237K Buy
5,799
+1,566
+37% +$67.6K 0.14% 157
2022
Q4
$217K Buy
+4,233
New +$203K 0.15% 171
2022
Q3
Sell
-4,737
Closed -$248K 186
2022
Q2
$248K Sell
4,737
-1,360
-22% -$69.3K 0.2% 150
2022
Q1
$316K Sell
6,097
-7,268
-54% -$377K 0.21% 140
2021
Q4
$789K Sell
13,365
-2,335
-15% -$116K 0.5% 71
2021
Q3
$675K Sell
15,700
-11,142
-42% -$494K 0.46% 73
2021
Q2
$1.05M Sell
26,842
-2,984
-10% -$116K 0.67% 52
2021
Q1
$1.08M Buy
29,826
+7,899
+36% +$280K 0.66% 44
2020
Q4
$805K Sell
21,927
-1,184
-5% -$43.4K 0.63% 44
2020
Q3
$805K Buy
23,111
+1,142
+5% +$40K 0.63% 45
2020
Q2
$682K Buy
21,969
+2,376
+12% +$80.7K 0.56% 52
2020
Q1
$607K Buy
+19,593
New +$668K 0.62% 45
2019
Q1
Sell
-7,970
Closed -$333K 195
2018
Q4
$333K Hold
7,970
0.27% 109
2018
Q3
$333K Buy
7,970
+691
+9% +$26.6K 0.26% 110
2018
Q2
$251K Buy
+7,279
New +$249K 0.22% 132

Other funds holding PFE

Ridgewood Investments's PFE Position: Q1 2026 in Review

Ridgewood Investments opened a new position in Pfizer (PFE) in Q1 2026: 38,948 shares worth $1.09M. The stake represents 0.45% of the portfolio and ranks #71 among its holdings. This is a return to the name: Ridgewood Investments previously reported a position in PFE as recently as Q3 2025.

Ridgewood Investments first reported a position in PFE in Q2 2018 and has held it in 26 quarters since. The position peaked at $1.59M in Q2 2024. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Ridgewood Investments held 38,948 shares of Pfizer worth $1.09M as of Q1 2026.
  • Pfizer was a new Ridgewood Investments position in Q1 2026.
  • Pfizer made up 0.45% of Ridgewood Investments's portfolio in Q1 2026, its #71 holding.
  • Ridgewood Investments first reported a position in Pfizer in Q2 2018 and has held it in 26 quarters since.
  • Ridgewood Investments's Pfizer position peaked at $1.59M in Q2 2024.
  • 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Ridgewood Investments's 13F filing for Q1 2026, filed 3 Apr 2026.